About BLOC-1-related complex subunit 6
BLOC-1-related complex subunit 6 (BORCS6) is a protein
from Homo sapiens identified by UniProt accession
Q96GS4, 357 residues long.
MolForge cross-references it against 0 known binders and
21 disease associations.
Target properties
| Protein name | BLOC-1-related complex subunit 6 |
| UniProt accession | Q96GS4 |
| Gene | BORCS6 |
| Organism | Homo sapiens |
| Length | 357 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (21)
Diseases linked to this target (Open Targets).
- Fraser syndrome · score 0.11
- memory impairment · score 0.09
- alcohol drinking · score 0.09
- apolipoprotein A 1 measurement · score 0.08
- high density lipoprotein cholesterol measurement · score 0.05
- hypoparathyroidism, familial isolated, 2 · score 0.04
- potassium measurement · score 0.04
- Primary hypomagnesemia with secondary hypocalcemia · score 0.04
- familial isolated hyperparathyroidism · score 0.04
- hyperparathyroidism · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96GS4-F1 | alphafold | PREDICTED | 65.39 | — |
Amino-acid sequence (357 residues)
MESSRGRPGP ETDLLAVAEH QALVFGGGPG RTSSEPPAGL RVSGEEETEN VGGANRHPRT SPKTSSCGVV HRPEREALEN EPGPQGTLSG AGSRRGAPGA EHEPSLSSRH KNPAPPEGKP SSGRDCRRGG PGGGMDVEQQ EEEDNDEEAA AGSRAGRSFS SRLQDSRSLD GLSEACGGAG SSGSAESGAG GGRRATISSP LELEGTVSRH GDLTHFVANN LQLKIRLSGA PPPPPSAPAR PCPAPAPTPT PAIPPIDPEV LRDLERLSRE LGGRVDRLLR GLGGAVQELT ALSVGCIQTY RDAVDSLGEA VDMSIKGMYT LLARCEELER ALQPVQGLAR QVRDIRRTLE VLEALCK
Explore BLOC-1-related complex subunit 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets